Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byMyriad Genetics
Price$270M
Date2/2014
TermsCash

General Information

Websitecrescendobio.com
Twitter@CrescendoBio
CategoryBioTech
Phone650-351-1354
Employees
Founded2002
DescriptionHealthcare Equipment/Supplies

Offices

South San Francisco, USA
400 East Jamie Court
Suite 100
South San Francisco, CA, 94080
USA

People

President and Chief Executive Officer
Vice President, Medical and Scientific Affairs
Vice President, Marketing and Sales
Vice President, Finance
Board Member
Board Member
Board Member
Board Member
Show All People

Funding

Tags

Crescendo Bioscience

Crescendo Bioscience, Inc. develops quantitative and objective diagnostic tools to provide rheumatologists with clinical insights to manage patients with autoimmune and inflammatory diseases. It provides diagnostic, prognostic, staging, therapy selection, and monitoring facilities to physicians. Crescendo Bioscience, Inc. was formerly known as Riley Genomics, Inc. The company was founded in 2002 and is based in South San Francisco, California.

Recent Milestones

Videos

Screenshots

Crescendo Bioscience screenshot
Above: Home Page
Uploaded: 12/1/09

Sources

  1. Myriad Genetics to Acquire Crescendo Bioscience® (crescendobio.com) [edit]
  2. SEC D/A (sec.gov) [edit]
  3. Crescendo Bioscience® Secures $56 Million in Funding to Expand Development and Commercialization of Personalized Diagnostics for Inflammatory Diseases (crescendobio.com) [edit]
  4. SEC (sec.gov) [edit]
  5. Crescendo Bioscience Raises $28M to Sell Arthritis-Tracking Blood Tests (pevc.dowjones.com) [edit]
Edit This Page
Last Edited 3/6/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy